General Information of This Metabolic Reaction (MR) (ID:
MR010934) |
Formula |
|
Reactant |
Lenvatinib |
Product |
N-descyclopropyl lenvatinib |
Reactant Info
|
Product Info
|
Metabolic Enzyme
|
Cytochrome P450 2B6 (CYP2B6)
|
DME Info
|
Cytochrome P450 3A4 (CYP3A4)
|
DME Info
|
Cytochrome P450 3A5 (CYP3A5)
|
DME Info
|
Metabolic Type
|
Unclear
-
Unclear
|
|
|
|
|
|
|
|
Other MR(s) Related to The Reactant of This MR |
Other MR(s) That Metabolize The Reactant of This MR
|
|
Other MR(s) Related to The Product of This MR |
Other MR(s) That Produce The Product of This MR
|
|
References |
1 |
The impact of individual human cytochrome P450 enzymes on oxidative metabolism of anticancer drug lenvatinib
|
2 |
Metabolite profiling of the multiple tyrosine kinase inhibitor lenvatinib: a cross-species comparison Invest New Drugs. 2016 Jun;34(3):300-18. doi: 10.1007/s10637-016-0342-y.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.